Try our Advanced Search for more refined results
Intellectual Property
-
February 10, 2026
Ex-Pro Basketball Player Denied Bid For College Hoops Return
Former NBA developmental league player Charles Bediako will not be able to keep competing for the University of Alabama after an Alabama state judge rejected his bid for an injunction overriding the NCAA's rules against professionals playing again in college.
-
February 10, 2026
2nd Circ. Revives Photographer's Case Against Shutterstock
The Second Circuit revived some of a landscape photographer's case against photo licensing database Shutterstock Inc. on Tuesday, finding that while there was nothing in evidence showing Shutterstock intended to change copyright management information, the company's "right and ability to control" the infringing activity should be litigated further.
-
February 10, 2026
Astellas Gets $90M From Lupin In Myrbetriq Patent Deal
Generic-drug maker Lupin Pharmaceuticals has inked a deal to pay $90 million to settle claims that it infringed patents held by rival Astellas Pharma Inc. covering name-brand bladder drug Myrbetriq.
-
February 10, 2026
Intellectual Property Group Of The Year: Gibson Dunn
Gibson Dunn & Crutcher LLP attorneys broke new ground in intellectual property matters last year, successfully defending Cisco in three big-dollar patent infringement cases and prevailing in a trademark dispute at the U.S. Supreme Court, earning the firm a place among the 2025 Law360 Intellectual Property Groups of the Year.
-
February 10, 2026
Food Slicer Rivals End Patent Case Weeks Before 3rd Trial
Weber Inc. and Provisur Technologies Inc. have told a federal district court and an appeals court that they were dismissing disputes between them over food slicer patents, ending a fight that saw a $21 million jury verdict thrown out and a second trial end in a mistrial.
-
February 10, 2026
Norton Rose Hires Cooley Life Sciences Duo In DC
Norton Rose Fulbright has hired two life sciences attorneys from Cooley LLP in Washington, D.C., who focus on biotech and pharmaceutical intellectual property matters, in a move the firm said is an investment in IP as a core practice.
-
February 10, 2026
Kilpatrick Brings On Perkins Coie Trademark Duo In Chicago
Kilpatrick Townsend & Stockton LLP has expanded its trademark, copyright and advertising team with two Perkins Coie LLP attorneys, including the former firmwide trademark, copyright, internet and advertising practice group chair.
-
February 09, 2026
6th Circ. Revives Drexel's Herbicide Contract Beef With Gowan
The Sixth Circuit on Monday held that a Tennessee federal court misinterpreted a profit-sharing agreement resolving an herbicide product registration dispute between Drexel Chemical Co. and Gowan Co. LLC, siding with Drexel on when the agreement terminated and reviving Drexel's suit over it.
-
February 09, 2026
Altar'd State Opens Bidding For Francesca's IP At $7M
Faith-based clothing retailer Altar'd State set an opening bid of $7 million for the intellectual property of bankrupt women's clothing retailer Francesca's, the debtor told a New Jersey bankruptcy judge Monday.
-
February 09, 2026
Fed. Circ. Mulls Whether Digital Ad Patent Can Survive Alice
An advertising management system company tried to persuade the Federal Circuit on Monday to revive its infringement suit against Google and YouTube, saying its patent was wrongly found to cover an abstract idea.
-
February 09, 2026
Autodesk Says Google Hijacked 'Flow' Video Production TM
Autodesk, which developed its "Flow" line of software for film, television and video game production, says Google has swooped in and taken the name for its own video production software app, allowing it to "swamp Autodesk's place in the market," according to a new lawsuit filed in California federal court.
-
February 09, 2026
Trump Names 2 Picks For ITC Commissioner Spots
President Donald Trump has nominated a counsel for the U.S. House of Representatives' intellectual property subcommittee and an assistant U.S. trade representative to be members of the U.S. International Trade Commission.
-
February 09, 2026
Paramount, Effects Co. Sue Each Other Over 'Scream' Mask
A special effects business and the entertainment companies behind the upcoming "Scream 7" film have filed lawsuits against one another in California federal court over the slasher movie franchise's iconic "Ghostface" mask.
-
February 09, 2026
Judge OKs Sanctions In Valve Fight, Warns More May Come
A Seattle federal judge on Monday granted video game maker Valve Corp.'s request to sanction a rival litigant over discovery violations just ahead of a trial on the company's allegations of bad faith patent infringement claims, and threatened to issue more over a legal brief that contained fake quotes and fabricated citations generated by artificial intelligence.
-
February 09, 2026
Fed. Circ. Uses Alice To Scrap $2.5M Netflix Patent Verdict
The Federal Circuit on Monday threw out a California jury's $2.5 million verdict against Netflix for infringing a GoTV Streaming LLC patent on wireless content delivery, agreeing with the streaming giant that the patent and two others are invalid because they cover only abstract ideas.
-
February 09, 2026
Kurin Fights $1.6M IP Verdict As Rival Seeks More Damages
Kurin has urged a Delaware federal judge to overturn Magnolia Medical's $1.6 million patent verdict or order a new trial, while Magnolia Medical has asked the court to bar Kurin from selling allegedly infringing "Jet" blood-culture collection products and award it supplemental damages on Kurin's sales, plus ongoing royalties and interest.
-
February 09, 2026
8th Circ. Lets Stand Minn. Law Banning Election Deepfakes
The Eighth Circuit on Monday declined to block Minnesota's law criminalizing deepfakes that are designed to influence elections, holding in a published opinion that a state legislator waited too long to seek emergency relief and that a political commentator who also challenged the statute did not have standing.
-
February 09, 2026
Tribal Corp. Says Colorado Consultant Misused Trade Secrets
An Alaskan tribal corporation is suing a Colorado consultant and her firm, alleging that she used its trade secret information to attempt to lure government contracting clients away by publicly advertising the data and claiming it as her own.
-
February 09, 2026
USPTO Targets Double-Dipping In Anon. Ex Parte Challenges
The U.S. Patent and Trademark Office is now requiring those who anonymously petition it to reexamine a patent's validity to certify that they haven't already challenged it at the Patent Trial and Appeal Board.
-
February 09, 2026
Videographer Fights 4th Circ.'s Choice To Shipwreck IP Suit
A videographer and his production company urged the full Fourth Circuit to let him revive his copyright infringement lawsuit over footage of Blackbeard's shipwreck, arguing Monday that a panel's recent opinion to end the case laid new and overly broad pathways for pendent jurisdiction.
-
February 09, 2026
Fed. Circ. Won't Reboot Startup's Patent Suit Against Shopify
The Federal Circuit on Monday declined to breathe new life into a case from a defunct digital media startup alleging that Shopify was infringing its patents by using ideas disclosed during talks about a potential partnership.
-
February 09, 2026
Fed. Circ. Sends Blood Pump Patent Fight Back To Mass.
The Federal Circuit on Monday reversed a lower court's ruling that Abiomed Inc. hasn't infringed five patents on blood pump systems and methods, while backing the part of the decision that cleared the medical device technology company of allegations it infringed a different patent.
-
February 09, 2026
'Baby Shark' Ruling Doesn't Stop Google Anti-Phishing Fight
A Manhattan federal judge granted injunctive relief Monday to Google in its effort to combat an alleged China-based phishing enterprise, holding that faraway defendants were properly served electronically despite an appellate ruling mandating mail service in a "Baby Shark" infringement case.
-
February 09, 2026
Novo Nordisk Sues Hims & Hers Over Knockoff GLP-1
Novo Nordisk AS followed through on Monday in Delaware federal court on a plan it announced last week to sue telehealth company Hims & Hers Health Inc. over its marketing of what Novo Nordisk calls a knockoff version of its GLP-1 medications.
-
February 09, 2026
Intellectual Property Group Of The Year: Susman Godfrey
Susman Godfrey LLP attorneys in the past year achieved some of the most closely watched victories in copyright, privacy and life sciences, including a record-setting copyright class settlement over books Anthropic obtained to train its flagship artificial intelligence model, earning the firm a spot among the 2025 Law360 Intellectual Property Groups of the Year.
Expert Analysis
-
How 2 Tech Statutes Are Being Applied To Agentic AI
The application of the Computer Fraud and Abuse Act and the California Invasion of Privacy Act to agentic artificial intelligence is still developing, but recent case law, like Amazon's lawsuit against Perplexity in California federal court, provides some initial guidance for companies developing or deploying these technologies, say attorneys at Weil.
-
FTC Focus: Testing Joint Enforcement Over Loyalty Programs
The Federal Trade Commission's case against Syngenta can be understood both as a canary for further scrutiny over loyalty-discount practices and a signal of the durability of joint federal-state antitrust enforcement, with key takeaways for practitioners and those subject to regulatory antitrust scrutiny alike, say attorneys at Proskauer.
-
NYC Bar Opinion Warns Attys On Use Of AI Recording Tools
Attorneys who use artificial intelligence tools to record, transcribe and summarize conversations with clients should heed the New York City Bar Association’s recent opinion addressing the legal and ethical risks posed by such tools, and follow several best practices to avoid violating the Rules of Professional Conduct, say attorneys at Smith Gambrell.
-
Series
The Biz Court Digest: Dispatches From Utah's Newest Court
While a robust body of law hasn't yet developed since the Utah Business and Chancery Court's founding in October 2024, the number of cases filed there has recently picked up, and its existence illustrates Utah's desire to be top of mind for businesses across the country, says Evan Strassberg at Michael Best.
-
Checking In On Biologics-Related Patent Review Trends
Comprehensive analysis of Patent Trial and Appeal Board data since the PTAB's creation indicates that while inter partes review and post-grant review are potent weapons for challenging biologics-related patents, recent policy changes may reduce their effectiveness, say attorneys at Steptoe.
-
4 Quick Emotional Resets For Lawyers With Conflict Fatigue
Though the emotional wear and tear of legal work can trap attorneys in conflict fatigue — leaving them unable to shake off tense interactions or return to a calm baseline — simple therapeutic techniques for resetting the nervous system can help break the cycle, says Chantel Cohen at CWC Coaching & Therapy.
-
Patent Eligibility Faces Widening Gap Between USPTO, Courts
The year 2026 opened with a profoundly altered Patent Act Section 101 ecosystem — the U.S. Patent and Trademark Office has pushed eligibility as far open as it can for artificial intelligence technologies, but the courts are not on the same page, say attorneys at Skadden.
-
Series
Playing Tennis Makes Me A Better Lawyer
An instinct to turn pain into purpose meant frequent trips to the tennis court, where learning to move ahead one point at a time was a lesson that also applied to the steep learning curve of patent prosecution law, says Daniel Henry at Marshall Gerstein.
-
Expect Major Shifts In Patent And Trademark Policy This Year
New leadership and initiatives promise to bring consequential changes to the U.S. Patent and Trademark Office's practices in 2026, likely favoring patent allowance and issuance, as well as streamlining trademark processes, say attorneys at Knobbe Martens.
-
And Now A Word From The Panel: MDL Year In Review
2025 was a roller coaster for the Judicial Panel on Multidistrict Litigation, with the panel canceling one hearing session due to the absence of new MDL petitions, yet also issuing rulings on more new MDL petitions than in 2024 — making it clear that MDLs are still thriving, says Alan Rothman at Sidley Austin.
-
Series
Judges On AI: How Judicial Use Informs Guardrails
U.S. Magistrate Judge Maritza Dominguez Braswell at the U.S. District Court for the District of Colorado discusses why having a sense of how generative AI tools behave, where they add value, where they introduce risk and how they are reshaping the practice of law is key for today's judges.
-
Evenflo IP Ruling Shows Evidence Is Still Key For Injunctions
Notwithstanding renewed policy and doctrinal attention to patent injunctions, the Federal Circuit's December decision in Wonderland v. Evenflo signals that the era of easily obtained patent injunctions has not yet arrived, say attorneys at King & Wood.
-
What US Cos. Must Know To Comply With Italy's AI Law
Italy's newly effective artificial intelligence law means U.S. companies operating in Italy or serving Italian customers must now meet EU AI Act obligations as well as Italy-specific requirements, including immediately enforceable criminal penalties, designated national authorities and sector-specific mandates, say attorneys at Portolano Cavallo.
-
Navigating Battery Validation Risk In The EV Supply Chain
Vehicle electrification has moved battery system supply chains from a background component into the center of the automotive universe — and for legal teams, battery validation is now a driver of contractual disputes, regulatory exposure and even shareholder litigation, say Samuel Madden at Secretariat Advisors and Vanessa Miller at Foley & Lardner.
-
Fed. Circ. In 2025: A Look At Continued USPTO Tensions
Unanticipated developments in 2025 included a tug-of-war between the Federal Circuit and the U.S. Patent and Trademark Office over inter partes review decisions, and this continued disparity looks set to contribute to another packed year for the court, say attorneys at Knobbe Martens.